University of Cambridge
The test, called Neutrocheck, relies on a lateral flow assay that can be run on a small, in-house devised device that can fit in the palm of a user.
ESHG: UK Study Finds 6 Percent of Renal Cell Carcinoma Patients Carry Cancer Risk Variant
Researchers looked for pathogenic or likely pathogenic variants in 121 cancer risk genes in whole-genome sequencing data from 1,336 unselected RCC patients.
Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK
The collaboration includes setting up a new testing laboratory that will investigate the use of alternative chemical reagents for test kits.
New Genetic Score Predicts Stroke Risk Better Than Established Risk Factors
The score's developers also suggest that current guidelines for stroke prevention may not be sufficient for individuals at higher genomic risk for the condition.
The number of technologies to be assessed is vast, and ranges from liquid biopsies and molecular imaging to immunohistochemistry and RNA-seq.
Jun 11, 2019
Nov 29, 2018
Jul 13, 2018
Apr 25, 2017